Ausgabe 3/2017
Inhalt (12 Artikel)
The Future of Targeting FLT3 Activation in AML
Mark B. Leick, Mark J. Levis
The Critical Role of Imaging in the Management of Multiple Myeloma
Shahzad Raza, Siyang Leng, Suzanne Lentzsch
Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Rochelle R. Maxwell, Peter D. Cole
Treatment of Young Adults with Acute Lymphoblastic Leukemia
Ankit Kansagra, Mark Litzow
New Therapeutic Strategies in Acute Lymphocytic Leukemia
Louise M. Man, Amy L. Morris, Michael Keng
Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma
Allison Rosenthal
A Review of Autologous Stem Cell Transplantation in Lymphoma
Umar Zahid, Faisal Akbar, Akshay Amaraneni, Muhammad Husnain, Onyee Chan, Irbaz Bin Riaz, Ali McBride, Ahmad Iftikhar, Faiz Anwer
Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?
Niloufer Khan, Alison J. Moskowitz
Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome
Sara Berg, Jennifer Villasenor-Park, Paul Haun, Ellen J. Kim
Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma
Victor J. Gonzalez
The Management of Lymphoma in the Setting of Pregnancy
Chelsea C Pinnix, Therese Y. Andraos, Sarah Milgrom, Michelle A. Fanale
Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies
Tarsheen K. Sethi, Basak Basdag, Nirmanmoh Bhatia, Javid Moslehi, Nishitha M. Reddy